Markers of proliferation in normal and leukoplakic oral epithelia

Oral Oncology

Volumn 36, Issue 2, 2000, Pages 145-151

  Liu, S C ^a   Klein Szanto, A J P ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Cyclin D1; Ki 67; Markers; Oral epithelia; Oral leukoplakia; PCNA; Proliferation

Indexed keywords

BROXURIDINE; CYCLIN D1; IDOXURIDINE; KI 67 ANTIGEN; MARKER; MONOCLONAL ANTIBODY; PROTEIN; THYMIDINE;

CELL PROLIFERATION; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MOUTH MUCOSA; PRIORITY JOURNAL; REVIEW;

EID: 0034162802     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00076-7     Document Type: Short Survey

References (47)

1. WHO Collaborating Center for Oral Precancerous Lesions Definition of leukoplakia and related lesion: an aid to studies on oral precancer. Oral Surg. Oral Med. Oral Pathol. 46:1978;518-539.
2. Burkhard A. Premaligne Veraenderungen der Mundschleimhaut. Der Pathologe. 6:1985;126-132.
3. Henson D.E., Albores-Saavedra J. Pathology of incipient neoplasia. 2nd ed. 1993;Saunders, Philadelphia.
4. Slaughter D.P., Southwick H.W., Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer. 6:1953;963-968.
5. Shin D.M., Varavud N., Ro J., Lee J., Hong W., Hittelman W.N. Sequential increase in proliferating cell nuclear antigen in head and neck tumorigenesis: a potential marker. J. Natl Cancer Inst. 85:1993;971-978.
6. Watling D.L., Gown A.M., Coltrera M.D. Overexpression of p53 in head and neck cancer. Head Neck. 14:1992;437-444.
7. Brennan J.A., Boyle J.O., Koch W.M., Goodman S.N., Hurban R.H., Eby Y.J., Couch M.J., Forastiere A.A., Sidransky D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. New Engl. J. Med. 332:1995;712-717.
8. Izzo J.G., Papadimitrakopoulou V.A., Li X.Q., Ibarguen H., Lee J.S., Ro J.Y., El-Naggar A., Hong W.K., Hittelman W.N. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 17:1998;2313-2322.
9. Mittal K.P., Demopoulos R.I., Goswami S. Proliferating cell nuclear antigen (cyclin) expression in normal and abnormal cervical squamous epithelia. Am. J. Surg. Pathol. 17:1993;117-122.
10. Warnakulasuriya K.A.A.S., MacDonald D.G. Epithelial cell kinetics in oral leukoplakia. J. Oral Pathol. Med. 24:1995;163-169.
11. Maidhof R., Prantle F., Hornstein O.P., Schell H. Zur proliferationskinetik der normalen und leukoplakischen Wangenmucosa. Arch. Dermatol. Res. 260:1977;193-200.
12. Loe H., Karring T., Hara K. The site of mitotic activity in rat and human oral epithelium. Scand. J. Dent. Res. 80:1972;111-119.
13. Rodriguez-Perez I., Sanabria-Negrin J., Banoczy J. Oral leukoplakia: nuclear volume and mitotic index. Acta Morphol. Hung. 32:1984;245-249.
14. Maidhof R., Prantle F., Hornstein O.P. Autographic study and some proliferative properties of human buccal mucosa. Arch. Dermatol. Res. 265:1979;165-172.
15. Kotelnikov V.M., Coon J.S., Taylor S., Hutchinson J., Pangje W., Caldarelli D.D., LaFollette H., Priesler H.D. Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer. Head and Neck. 18:1996;522-528.
16. Gallo O., Franchi A., Chiarelli I., Portfirio B., Grande A., Simonetti L., Boccionlini C., Fini-Storchi O. Potential biomarkers in predicting progression of epithelial hyperplastic lesion of larynx. Acta Otolaryngol. 537(Suppl.):1997;30-38.
17. Huang W.Y., Coltera M., Schubert M., Morton T., Truelove E. Histologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions. Oral Surg. Oral Med. Oral Pathol. 78:1994;748-754.
18. Kyomoto R., Kumazawa H., Toda Y., Sakaida N., Okamura A., Iwanaga M., Shintaku M., Yamashita T., Hiai H., Fukumoto M. Cyclin D1 gene amplification is a more potent prognostic factor than its protein over-expression in human head and neck squamous cell carcinomas. Int. J. Cancer. 74:1997;576-581.
19. Martinez-Lara I., Gonzalez-Moles M.A., Ruiz-Avila I., Bravo M., Ramos M.C., Fernandez-Martinez J.A. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa. Acta Stomatol. Belg. 93:1996;29-32.
20. Rishi M., Schwarting R., Kovatich A.J., Ehya H. Detecting the growth fraction in tumor of Ki-67 monoclonal antibody in cytologic smears: a prospective study of 40 cases. Diagn. Cytopathol. 9:1993;52-58.
21. Tamboli P., Amin M.B., Schultz D.S., Linden M.D., Kubus J. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate intraepithelial neoplasia, and prostatic carcinoma. Mod. Pathol. 9:1996;1015-1019.
22. Huber M.H., Lippman S.M., Hong W.K. Chemoprevention of head and neck cancer. Sem. Oncol. 3:1994;366-375.
23. Silverman S., Gorsky M., Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer. 53:1984;563-568.
24. Bartkova J., Lukas J., Muller H., Strauss M., Gusterson B., Bartek J. Pattern of D type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 55:1995;949-956.
25. Coltera M.D., Zarbo R.J., Sakr W.A., Gown A.M. Markers for dysplasia of upper aerodigestive tract: suprabasal expression of PCNA, P53, and CK19 in alcohol-fixed, embedded tissue. Am. J. Pathol. 141:1992;817-825.
26. Matsuda M., Hirakawa N., Nakashima T., Kuratomi Y., Komiyama S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer. 78:1996;390-395.
27. Michalides R., van Veelen N., Hart A., Loftus B., Wientjens E., Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 55:1995;975-978.
28. Sauter E.R., Cleveland D., Trock B., Ridge J.A., Klein-Szanto A.J.P. P53 overexpression increases gradually with progression in premalignant lesions of the head and neck epithelium. Carcinogenesis. 15:1994;2269-2274.
29. Shin D.M., Kim J., Ro J.Y., Hittleman J., Roth J.A., Hong W.K., Hittleman W.N. Activition of p53 expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 54:1994;321-326.
30. Uhlman D.L., Adams G., Knapp D., Aeppli D.M., Niehans G. Immunohistochemical staining for markers of future neoplastic progression in the larynx. Cancer Res. 56:1996;2199-2205.
31. Wedenberg C., Johnson A., Jirsh J.M. Assessemnt of p53 and Ki-67 expression in snuff-induced lesions. Br. J. Oral Maxillofac. Surg. 34:1996;409-413.
32. Liu S.C., Sauter E.R., Clapper M.L., Feldman R.S., Levin L., Chen S.Y., Yen T.J., Ross E., Engstrom P.F., Klein-Szanto A.J. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. Cancer Epidemiol. Biomarkers Prev. 7:1998;597-603.
33. Verheijen R., Kuijpers H.J.H., Schlingeman R.O., Boehmer A.L.M., van Driel R., Brakenhoff G.J. Ki-67 detects a nuclear matrix-associated proliferation-related antigen: 1. Intracellular localization during interphase. J. Cell Sci. 92:1989;123-130.
34. Youssef E.M., Matsuda T., Takada N., Osugi H., Higashino M., Kinoshita H., Watanabe T., Katsura Y., Wanihuchi H., Fukushima S. Prognostic significance of the Mib-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer. 76:1995;358-366.
35. Gerdes A.J., Li J., Schlueter C., Duchrow M., Wohlenberg C., Gerlach C. Immunohistochemical and molecular biologic characterization of cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 138:1991;867-873.
36. Okuno Y., Nishimura Y., Kashu I., Ono K., Hiraoka M. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of esophageal squamous cell carcinoma. Br. J. Cancer. 80(3/4):1999;387-395.
37. Sherr C.J. D-type cyclins. Trends Biochem. Sci. 20:1995;187-190.
38. Weinstein I.B. Relavance of cyclin D1 and other molecular markers to cancer chemoprevention. J. Cellular Biochem. 25(s):1996;23-28.
39. Callender T., El-Naggar A.K., Lee M.S., Frankenthaler R., Luna M.A., Batsakis J.G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Philadelphia). 74:1994;152-158.
40. Jares P., Fernandez P.L., Campo E., Nadal A., Bosch F., Aiza G., Nayach I., Traserra J., Cardesa A. PRAD-1/cyclin D1 gene amplification correlates with messager RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 54:1994;4813-4817.
41. Bellacosa A., Almadori G., Cavallo S., Cadoni G., Galli J., Ferrandina G., Scambia G., Neri G. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin. Cancer Res. 2:1996;175-180.
42. Liao H., Winkfein R.J., Mack G., Rattner J.B., Yen T.J. CENP-F is a protein of the nuclear matrix that assesmbles into kinetochores at late G2 and is rapidly degraded after mitosis. J. Cell Biol. 130:1995;507-518.
43. Skougard A.O., Skougard M.R., Pindborg J.J., Roed-Petersen B. In vitro incorporation of tritiated thymidine in homogenous leukoplakias. Scand. J. Dent. Res. 80:1972;510-514.
44. Klein-Szanto A.J.P., Banoczy J., Schroeder H.E. Metaplastic conversion of the differentiation pattern in oral epithelia affected by leukoplakia simplex. A stereologic study. Pathol. Eur. 11:1976;189-210.
45. Renstrup G. Studies in the oral leukoplakias IV. Mitotic activity. Acta Odontol. Scand. 21:1963;233-340.
46. Slootweg P.J., Koole R., Hordijk G.J. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adajcent dysplasia mucosa. Oral Oncol. Eur. J. Cancer. 30(B):1994;138-141.
47. Kotelnikov V.M., Coon J.S., Mundle S., Kelanic S., LaFollette S., Taylor S., Hutchinson J., Panje W., Caldarelli, Preisler H.D. Cyclin D1 expression in squamous cell carcinomas of head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res. 3:1997;95-101.